位置:首页 > 蛋白库 > PIDD1_MOUSE
PIDD1_MOUSE
ID   PIDD1_MOUSE             Reviewed;         915 AA.
AC   Q9ERV7; A6H6F4;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 146.
DE   RecName: Full=p53-induced death domain-containing protein 1 {ECO:0000305};
DE            EC=3.4.21.- {ECO:0000250|UniProtKB:Q9HB75};
DE   AltName: Full=Leucine-rich repeat and death domain-containing protein;
DE   Contains:
DE     RecName: Full=PIDD-N {ECO:0000250|UniProtKB:Q9HB75};
DE   Contains:
DE     RecName: Full=PIDD-C {ECO:0000250|UniProtKB:Q9HB75};
DE   Contains:
DE     RecName: Full=PIDD-CC {ECO:0000250|UniProtKB:Q9HB75};
GN   Name=Pidd1 {ECO:0000312|MGI:MGI:1889507};
GN   Synonyms=Lrdd, Pidd {ECO:0000303|PubMed:10973264};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION, AND FUNCTION.
RX   PubMed=10973264; DOI=10.1038/79102;
RA   Lin Y., Ma W., Benchimol S.;
RT   "Pidd, a new death-domain-containing protein, is induced by p53 and
RT   promotes apoptosis.";
RL   Nat. Genet. 26:122-127(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH CRADD.
RX   PubMed=22279524; DOI=10.1371/journal.pone.0028936;
RA   Puffenberger E.G., Jinks R.N., Sougnez C., Cibulskis K., Willert R.A.,
RA   Achilly N.P., Cassidy R.P., Fiorentini C.J., Heiken K.F., Lawrence J.J.,
RA   Mahoney M.H., Miller C.J., Nair D.T., Politi K.A., Worcester K.N.,
RA   Setton R.A., Dipiazza R., Sherman E.A., Eastman J.T., Francklyn C.,
RA   Robey-Bond S., Rider N.L., Gabriel S., Morton D.H., Strauss K.A.;
RT   "Genetic mapping and exome sequencing identify variants associated with
RT   five novel diseases.";
RL   PLoS ONE 7:E28936-E28936(2012).
CC   -!- FUNCTION: Component of the DNA damage/stress response pathway that
CC       functions downstream of p53/TP53 and can either promote cell survival
CC       or apoptosis (PubMed:10973264). Associated with CRADD and the CASP2
CC       caspase, it forms the PIDDosome a complex that activates CASP2 and
CC       triggers apoptosis. Associated with IKBKG and RIPK1, it enhances
CC       sumoylation and ubiquitination of IKBKG which is important for
CC       activation of the transcription factor NF-kappa-B (By similarity).
CC       {ECO:0000250|UniProtKB:Q9HB75, ECO:0000269|PubMed:10973264}.
CC   -!- SUBUNIT: Forms a complex named the PIDDosome with CASP2 and CRADD
CC       (PubMed:22279524). Forms a complex with IKBKG and RIPK1. Interacts with
CC       FADD and MADD (By similarity). {ECO:0000250|UniProtKB:Q9HB75,
CC       ECO:0000269|PubMed:22279524}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9HB75}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9HB75}. Note=Enriched in the nucleus upon DNA
CC       damage. {ECO:0000250|UniProtKB:Q9HB75}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10973264}.
CC   -!- INDUCTION: Induced by TP53/tumor suppressor p53 AND gamma-irradiation.
CC       {ECO:0000269|PubMed:10973264}.
CC   -!- DOMAIN: The Death domain mediates the interaction with CRADD and the
CC       formation of a complex composed of 5 PIDD1 and 7 CRADD proteins which
CC       in turn recruit 7 CASP2 to form the PIDDosome.
CC       {ECO:0000250|UniProtKB:Q9HB75}.
CC   -!- DOMAIN: The LRR repeat-containing domain has a regulatory activity,
CC       being autoinhibitory for the activation of NF-kappa-B.
CC       {ECO:0000250|UniProtKB:Q9HB75}.
CC   -!- PTM: Undergoes autoproteolytic processing whose extent either directs
CC       cells towards survival or apoptotic pathways. Autoproteolytically
CC       cleaved into two main fragments PIDD-N and PIDD-C. PIDD-C can be
CC       further processed into PIDD-CC, a processing which is enhanced by DNA
CC       damage. The cleavage producing PIDD-C is required for translocation of
CC       PIDD1 to the nucleus upon DNA damage and activation of NF-kappa-B.
CC       PIDD-CC mediates the interaction with CRADD and the cleavage producing
CC       PIDD-CC is required for the activation of CASP2. PIDD-N remains
CC       associated with PIDD-C and PIDD-CC after cleavage.
CC       {ECO:0000250|UniProtKB:Q9HB75}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF274973; AAG13462.1; -; mRNA.
DR   EMBL; BC145857; AAI45858.1; -; mRNA.
DR   CCDS; CCDS22014.1; -.
DR   RefSeq; NP_073145.1; NM_022654.1.
DR   RefSeq; XP_006536281.1; XM_006536218.3.
DR   AlphaFoldDB; Q9ERV7; -.
DR   SMR; Q9ERV7; -.
DR   BioGRID; 208363; 3.
DR   ComplexPortal; CPX-3963; Caspase-2 PIDDosome.
DR   STRING; 10090.ENSMUSP00000026580; -.
DR   iPTMnet; Q9ERV7; -.
DR   PhosphoSitePlus; Q9ERV7; -.
DR   EPD; Q9ERV7; -.
DR   MaxQB; Q9ERV7; -.
DR   PaxDb; Q9ERV7; -.
DR   PRIDE; Q9ERV7; -.
DR   ProteomicsDB; 289421; -.
DR   Antibodypedia; 22664; 169 antibodies from 25 providers.
DR   DNASU; 57913; -.
DR   Ensembl; ENSMUST00000026580; ENSMUSP00000026580; ENSMUSG00000025507.
DR   Ensembl; ENSMUST00000106005; ENSMUSP00000101627; ENSMUSG00000025507.
DR   GeneID; 57913; -.
DR   KEGG; mmu:57913; -.
DR   UCSC; uc009klc.1; mouse.
DR   CTD; 55367; -.
DR   MGI; MGI:1889507; Pidd1.
DR   VEuPathDB; HostDB:ENSMUSG00000025507; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG4177; Eukaryota.
DR   GeneTree; ENSGT00940000161780; -.
DR   HOGENOM; CLU_017883_0_0_1; -.
DR   InParanoid; Q9ERV7; -.
DR   OMA; HRDNLGA; -.
DR   OrthoDB; 176487at2759; -.
DR   PhylomeDB; Q9ERV7; -.
DR   TreeFam; TF331183; -.
DR   Reactome; R-MMU-6803207; TP53 Regulates Transcription of Caspase Activators and Caspases.
DR   BioGRID-ORCS; 57913; 2 hits in 75 CRISPR screens.
DR   ChiTaRS; Pidd1; mouse.
DR   PRO; PR:Q9ERV7; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q9ERV7; protein.
DR   Bgee; ENSMUSG00000025507; Expressed in nasal cavity respiratory epithelium and 105 other tissues.
DR   ExpressionAtlas; Q9ERV7; baseline and differential.
DR   Genevisible; Q9ERV7; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:1905369; C:endopeptidase complex; ISO:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0005730; C:nucleolus; IC:ComplexPortal.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:MGI.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IGI:MGI.
DR   GO; GO:0006915; P:apoptotic process; ISO:MGI.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IGI:MGI.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; ISO:MGI.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; ISO:MGI.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IGI:MGI.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IGI:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IC:ComplexPortal.
DR   GO; GO:0016540; P:protein autoprocessing; ISO:MGI.
DR   GO; GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; ISO:MGI.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 1.10.533.10; -; 1.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR019502; Peptidase_S68_pidd.
DR   InterPro; IPR000906; ZU5_dom.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF13855; LRR_8; 2.
DR   Pfam; PF10461; Peptidase_S68; 1.
DR   Pfam; PF00791; ZU5; 2.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00369; LRR_TYP; 7.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS51450; LRR; 7.
DR   PROSITE; PS51145; ZU5; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; Cytoplasm; Hydrolase; Leucine-rich repeat; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT   CHAIN           2..915
FT                   /note="p53-induced death domain-containing protein 1"
FT                   /id="PRO_0000245244"
FT   CHAIN           2..450
FT                   /note="PIDD-N"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT                   /id="PRO_0000445718"
FT   CHAIN           451..915
FT                   /note="PIDD-C"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT                   /id="PRO_0000445719"
FT   CHAIN           594..915
FT                   /note="PIDD-CC"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT                   /id="PRO_0000445720"
FT   REPEAT          131..152
FT                   /note="LRR 1"
FT   REPEAT          154..176
FT                   /note="LRR 2"
FT   REPEAT          177..199
FT                   /note="LRR 3"
FT   REPEAT          200..221
FT                   /note="LRR 4"
FT   REPEAT          223..245
FT                   /note="LRR 5"
FT   REPEAT          246..268
FT                   /note="LRR 6"
FT   REPEAT          269..290
FT                   /note="LRR 7"
FT   DOMAIN          327..459
FT                   /note="ZU5 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          460..601
FT                   /note="ZU5 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   DOMAIN          793..878
FT                   /note="Death"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00064"
FT   REGION          428..457
FT                   /note="Peptidase S68"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   REGION          571..599
FT                   /note="Peptidase S68"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00485"
FT   REGION          585..721
FT                   /note="UPA domain"
FT                   /evidence="ECO:0000250"
FT   REGION          888..915
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        898..915
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        449
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75,
FT                   ECO:0000255|PROSITE-ProRule:PRU00485"
FT   ACT_SITE        451
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75,
FT                   ECO:0000255|PROSITE-ProRule:PRU00485"
FT   ACT_SITE        591
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75,
FT                   ECO:0000255|PROSITE-ProRule:PRU00485"
FT   ACT_SITE        593
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75,
FT                   ECO:0000255|PROSITE-ProRule:PRU00485"
FT   SITE            450..451
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT   SITE            592..593
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HB75"
SQ   SEQUENCE   915 AA;  101141 MW;  49FAA7B91D08E135 CRC64;
     MAAVLEGQEP EETAAAAEDA ATSTLEAVDA GPGAPFLPAG NQLNLDLRPG GCHRLQYLCS
     QQPPQLLQVE FLRLSTHEDP QLLDDTLAKV PWSLLRLRSL VLKGGQSRGA LGACLHGTLT
     TLPAGLSDLA CLAHLDLSFN RLETLPTCVP ELHGLDALLL SHNHLSELPE ALGALPALTF
     LTVTHNRLER LPLTLGSLST LQRLDLSENL LDTIPSEIGN LRSLSELNLA SNRLQSLPAS
     LAGLRSLRLL VLHSNLLTSV PTGLVHLPLI TRLDLRDNRL RDLPAELLDA PFVRLQGNPL
     GEASPAPPSP PDISQVPEMP RLLLTSDLDS FLVTPHGCSV TLACGVRLQF PAGATTTPVT
     IHYRLWLPEP GLVSLGPHDF LLSSVLELQP HGVAFQQDVS LWLLFVPPRV RRCREVVVRT
     RSNNTWNDLE TQLEEEAPKR LWARCQVPHF SWFLVVLRPV SNTCLLPPEG ALLCSSGHPG
     VRVTFPPGVT EEPRQVSMQV VHMAGLELRT LLEESEASVS PLLCLSQSGP PSFLQPVTVQ
     LPLPPGVTGF SLDRSHLHLL YRTPLTTTWD DITTQVALEF THLYARFQVT HFSWYWLWYT
     TKTCVGGLAR KAWERLRLHR VNLIALQRRR DPEQVLLQCL PRNKVDATLS RLLVRYRGPE
     PSETVEMFEG EKFFAAFERG IDVDADRPDC VDGRICFVFY SHLKNVKEVY ITTALDREAQ
     DVRGQVSFYR GSLPVEVPAE AEAARQRKGT DALWMATLPI KLPRLRGAQG SGQGTDFSLM
     PLNLGDAETG FLTQSNLLSV ASRLGPDWPA VALHLGMPYH KLQRIRHEFR DDLDGQVRHM
     LFSWAERQTG QPGAVGHLVQ ALEQSDRRDV AEEVRAILEL GRHKYQDSIR RTGLAPEDST
     LPGTSASQTP ESAQA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024